GLC Medical (GLCM) Inc.
We are a Canadian graphene technology company producing platform technologies which offer new and innovative first-to-market products and solutions.
Who are we?
Following the spread of this global pandemic, GLC Medical (GLCM) Inc. was founded to carry out the research, product development and commercialization of our SARS-CoV-2 Insta-Test that uses GLC’s graphene platform technology. Our graphene technology can ultimately be tailored to detect other types of viruses and pathogen, offering a technology that can be used for developing various sensory devices for medical purposes. GLC is investing heavily on further research and development for pioneering graphene applications in Health Innovation.
Our latest project
Time is crucial in containing the spread of Covid-19 and the race to develop a tool for rapid testing is critical. GLC Medical (GLCM) Inc. has been working in the background from the very start of this pandemic, using its graphene technology to create a solution that would help bring ‘normal’ back to businesses, communities and loved ones.
Having a non-intrusive point-of-care diagnostic testing tool on a massive scale that can respond instantly to virus in saliva, will enable more screening and testing so that economies can begin to reopen, and society can gradually return to public venues and social events safely. Organizations of all sizes will be able to ensure with confidence that their employees and clientele are comfortably screened and can return to a safe environment.
In The News
Check out our latest news posting and publications.
Donna Mandau, President and CEO of Graphene Leaders Canada, speaks with Ryan Jespersen about creating the “world’s first” Covid-19 Rapid Detection Test.
GLCM is pleased to report it has completed development of the graphene-enhanced sensor used in the rapid test kit.
Looking for more?
We're here to answer any questions you may have about our graphene products and application solutions